Matinas BioPharma Holdings, Inc. (MTNB) › Total LiabilitiesMatinas BioPharma Holdings, Inc. (MTNB) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2013: $859.0K2014: $1.13M2015: $2.33M2016: $2.67M2017: $3.74M2018: $3.80M2019: $7.19M2020: $7.24M2021: $8.83M2022: $8.18M2023: $5.86M2024: $5.05M2025: $2.38M$2.38M2013Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$2.38M-52.9%2024$5.05M-13.8%2023$5.86M-28.4%2022$8.18M-7.4%2021$8.83M+22.0%2020$7.24M+0.7%2019$7.19M+89.1%2018$3.80M+1.6%2017$3.74M+40.3%2016$2.67M+14.3%2015$2.33M+105.9%2014$1.13M+32.0%2013$859.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share